首页|国际ADHD非药物干预指南解读

国际ADHD非药物干预指南解读

扫码查看
注意缺陷多动障碍(ADHD)是一种神经系统发育障碍,目前患病率呈上升趋势,ADHD治疗应采用药物治疗和非药物治疗相结合的多模式综合治疗,但目前临床以药物治疗为主,对于非药物治疗的应用我国尚处于起步阶段,故而本文对美国、加拿大、英国、德国、新加坡等国家的6篇ADHD指南进行详细分析,重点提取了非药物治疗相关具体内容,再结合我国国情深入分析,为探索符合我国ADHD非药物治疗模式提供帮助。
Interpretation of international guidelines for non-drug intervention in ADHD
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder, and its incidence is currently on the rise. ADHD treatment should adopt a multimodal comprehensive approach, including both pharmacological and non-pharmacological interventions. However, current clinical practice mainly relies on pharmacological treatments, and non-pharmacological interventions are still in their early stages in China. Therefore, this article provides a detailed analysis of six ADHD guidelines from the United States, Canada, the United Kingdom, Germany, and Singapore, focusing on non-pharmacological interventions. By combining the specific content of non-pharmacological interventions with China's national conditions, this article aims to provide help for exploring a non-pharmacological treatment model that suits ADHD in China.

戚艳杰、何凡、郑毅

展开 >

100088 北京,首都医科大学附属北京安定医院,国家精神心理疾病临床医学研究中心,精神疾病诊断与治疗北京市重点实验室

100069 北京,首都医科大学人脑保护高精尖创新中心

注意缺陷多动障碍 非药物干预 指南 儿童 青少年

北京市科委中关村管委会资助

Z22111000350000

2023

中华临床医师杂志(电子版)
中华医学会

中华临床医师杂志(电子版)

CSTPCD
影响因子:0.99
ISSN:1674-0785
年,卷(期):2023.17(10)
  • 2